金河生物：2025年金霉素预混剂与疫苗都将放量

Core Insights - The company has received approval for its sheep-use chloramphenicol premix, expected to be promoted heavily in 2025, with an anticipated increase of over 20,000 tons in domestic ruminant chloramphenicol premix usage in the future [1] - The company's brucellosis vaccine has recently won a procurement project from a large enterprise, with gradual market release expected in 2025 due to its superior safety profile [1] - Additional vaccines, including the porcine pseudorabies (gene-deleted inactivated vaccine), bovine nodular skin disease inactivated vaccine, porcine Japanese encephalitis inactivated vaccine, and new adenovirus four-in-one inactivated vaccine, are expected to be launched in 2025 [1]